|Articles|July 27, 2019

ASRS 2019 Street Team: David S. Boyer, MD

Author(s)Ophthalmology Times Staff Reports

David S. Boyer, MD, notes that the goal is to dry every patient out, with undertreatment the leading cause of a loss of visual acuity.

David S. Boyer, MD, shares the take-home message from the presentation he delivered at the 2019 meeting of the American Society of Retina Specialists, "The Average Patient Does Not Enter Your Office: What Can We Learn About Treating nAMD From Individual Patient Responses."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe

Latest CME

In-Person + Virtual Event

Retina Updates in Montréal

July 16-17, 2026

ASRS 2019 Street Team: David S. Boyer, MD

Newsletter

Related Content

Redefining the possible: MCO-010’s 3-year retinal data

Could FLIO predict how fast geographic atrophy will grow?

Vaccinated patients show markedly lower risk of new-onset idiopathic uveitis

Revakinagene taroretcel-lwey for MacTel: Charles Wykoff, MD, PhD, on a year of real-world experience

Detecting peripheral retinal lesions in children with myopia

Latest CME

Retina Updates in Montréal

PER Global Perspectives: The TROP2-Targeted ADC Landscape in NSCLC and How to Interpret the Evidence

PER Global Perspectives: Differentiating and Managing Toxicities with TROP2-Targeted ADCs in NSCLC Through Multidisciplinary Pathways

Rapid Reviews in Retina™: Emerging Updates from Spring 2025—Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease

Interventional Dry Eye: A Stepwise Treatment & Management Approach

(CME Track) Rapid Reviews in Retina™: Emerging Updates from Summer 2025—Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease

(CME Track) Community Collaborative Connections™: Optimizing the Collaborative Care of Neovascular Retinal Disease in a New Age of Treatment

(CME Track) The Evolution of MacTel Management: Integrating Neuroprotective Therapies Into Clinical Practice

(CME Track) Collaborating Across the Continuum™: Best Practices in Patient-Centric Team Management of XLRP

(CME Track) A Forward Look at Anti-VEGF Therapies: A Paradigm Shift in Neovascular Retinal Disease Management

Navigating Advances in Neovascular Retinal Disease: Translating Evidence to Practice in AMD, DME, and RVO

(CME Track) Beyond the Collarette: Empowering Patients in the Management of Demodex Blepharitis

Rapid Reviews in Retina™: Emerging Updates from Fall 2025—Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - California

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - NYC Metro

When Mites Meet Their Match: Empowering Patients With Targeted Treatment for 𝘋𝘦𝘮𝘰𝘥𝘦𝘹 Blepharitis

The Presbyopia-Correcting and Toric IOL Playbook: Game-Changing Surgical Strategies to Enhance Patient Outcomes

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - Florida

Trending on Eye Care Network - Ophthalmology Times

FDA grants RMAT designation to Emmecell's EO2002 for corneal endothelial disease

NeuroOp Guru: What a big data study reveals about NAION and stroke risk

Offline smartphone AI accurately detects DR, glaucoma, and AMD in real-world study

Port Delivery System Therapies in Retinal Vascular Diseases

Polyendocrine metabolic ovarian syndrome: looking past the reproductive system to the eye